499 related articles for article (PubMed ID: 32094077)
1. Inhibitory effects of glycopyrronium, formoterol, and budesonide on coronavirus HCoV-229E replication and cytokine production by primary cultures of human nasal and tracheal epithelial cells.
Yamaya M; Nishimura H; Deng X; Sugawara M; Watanabe O; Nomura K; Shimotai Y; Momma H; Ichinose M; Kawase T
Respir Investig; 2020 May; 58(3):155-168. PubMed ID: 32094077
[TBL] [Abstract][Full Text] [Related]
2. Formoterol and budesonide inhibit rhinovirus infection and cytokine production in primary cultures of human tracheal epithelial cells.
Yamaya M; Nishimura H; Nadine L; Kubo H; Nagatomi R
Respir Investig; 2014 Jul; 52(4):251-60. PubMed ID: 24998372
[TBL] [Abstract][Full Text] [Related]
3. Procaterol inhibits rhinovirus infection in primary cultures of human tracheal epithelial cells.
Yamaya M; Nishimura H; Hatachi Y; Yoshida M; Fujiwara H; Asada M; Nakayama K; Yasuda H; Deng X; Sasaki T; Kubo H; Nagatomi R
Eur J Pharmacol; 2011 Jan; 650(1):431-44. PubMed ID: 20940011
[TBL] [Abstract][Full Text] [Related]
4. Budesonide and formoterol effects on rhinovirus replication and epithelial cell cytokine responses.
Bochkov YA; Busse WW; Brockman-Schneider RA; Evans MD; Jarjour NN; McCrae C; Miller-Larsson A; Gern JE
Respir Res; 2013 Oct; 14(1):98. PubMed ID: 24219422
[TBL] [Abstract][Full Text] [Related]
5. Transcriptome-Level Interactions between Budesonide and Formoterol Provide Insight into the Mechanism of Action of Inhaled Corticosteroid/Long-Acting
Mostafa MM; Rider CF; Wathugala ND; Leigh R; Giembycz MA; Newton R
Mol Pharmacol; 2021 Mar; 99(3):197-216. PubMed ID: 33376135
[TBL] [Abstract][Full Text] [Related]
6. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
[TBL] [Abstract][Full Text] [Related]
7. Human coronavirus 229E infects polarized airway epithelia from the apical surface.
Wang G; Deering C; Macke M; Shao J; Burns R; Blau DM; Holmes KV; Davidson BL; Perlman S; McCray PB
J Virol; 2000 Oct; 74(19):9234-9. PubMed ID: 10982370
[TBL] [Abstract][Full Text] [Related]
8. Long-acting β
Altonsy MO; Mostafa MM; Gerber AN; Newton R
Am J Physiol Lung Cell Mol Physiol; 2017 Mar; 312(3):L358-L370. PubMed ID: 28039105
[TBL] [Abstract][Full Text] [Related]
9. The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults.
Darken P; DePetrillo P; Reisner C; St Rose E; Dorinsky P
Pulm Pharmacol Ther; 2018 Jun; 50():11-18. PubMed ID: 29544728
[TBL] [Abstract][Full Text] [Related]
10. Clinical Isolates of Human Coronavirus 229E Bypass the Endosome for Cell Entry.
Shirato K; Kanou K; Kawase M; Matsuyama S
J Virol; 2017 Jan; 91(1):. PubMed ID: 27733646
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological characterisation of the interaction between glycopyrronium bromide and indacaterol fumarate in human isolated bronchi, small airways and bronchial epithelial cells.
Cazzola M; Calzetta L; Puxeddu E; Ora J; Facciolo F; Rogliani P; Matera MG
Respir Res; 2016 Jun; 17(1):70. PubMed ID: 27296533
[TBL] [Abstract][Full Text] [Related]
12. Beclomethasone dipropionate, formoterol fumarate and glycopyrronium bromide: Synergy of triple combination therapy on human airway smooth muscle ex vivo.
Rogliani P; Matera MG; Facciolo F; Page C; Cazzola M; Calzetta L
Br J Pharmacol; 2020 Mar; 177(5):1150-1163. PubMed ID: 31660611
[TBL] [Abstract][Full Text] [Related]
13. Increased rhinovirus replication in nasal mucosa cells in allergic subjects is associated with increased ICAM-1 levels and endosomal acidification and is inhibited by L-carbocisteine.
Yamaya M; Nomura K; Arakawa K; Nishimura H; Lusamba Kalonji N; Kubo H; Nagatomi R; Kawase T
Immun Inflamm Dis; 2016 Jun; 4(2):166-181. PubMed ID: 27957326
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication.
Marcellini A; Swieboda D; Guedán A; Farrow SN; Casolari P; Contoli M; Johnston SL; Papi A; Solari R
Eur J Pharmacol; 2021 Feb; 893():173839. PubMed ID: 33359650
[TBL] [Abstract][Full Text] [Related]
15. Relative Bioavailability of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Administered With and Without a Spacer: Results of a Phase I, Randomized, Crossover Trial in Healthy Adults.
Dorinsky P; DePetrillo P; DeAngelis K; Trivedi R; Darken P; Gillen M
Clin Ther; 2020 Apr; 42(4):634-648. PubMed ID: 32253054
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of long-acting β
Kim Y; Hou V; Huff RD; Aguiar JA; Revill S; Tiessen N; Cao Q; Miller MS; Inman MD; Ask K; Doxey AC; Hirota JA
Respir Res; 2021 Oct; 22(1):266. PubMed ID: 34666750
[TBL] [Abstract][Full Text] [Related]
17. The bronchodilator effects of extrafine glycopyrronium added to combination treatment with beclometasone dipropionate plus formoterol in COPD: A randomised crossover study (the TRIDENT study).
Singh D; Schröder-Babo W; Cohuet G; Muraro A; Bonnet-Gonod F; Petruzzelli S; Hoffmann M; Siergiejko Z;
Respir Med; 2016 May; 114():84-90. PubMed ID: 27109816
[TBL] [Abstract][Full Text] [Related]
18. Corticosteroids plus long-acting β2-agonists prevent double-stranded RNA-induced upregulation of B7-H1 on airway epithelium.
Kan-O K; Matsumoto K; Inoue H; Fukuyama S; Asai Y; Watanabe W; Kurokawa M; Araya J; Kuwano K; Nakanishi Y
Int Arch Allergy Immunol; 2013; 160(1):27-36. PubMed ID: 22948082
[TBL] [Abstract][Full Text] [Related]
19. Single inhaler triple therapy with extrafine beclomethasone, formoterol, and glycopyrronium for the treatment of chronic obstructive pulmonary disease.
Singh D
Expert Opin Pharmacother; 2018 Aug; 19(11):1279-1287. PubMed ID: 29985096
[TBL] [Abstract][Full Text] [Related]
20. Infection of human alveolar macrophages by human coronavirus strain 229E.
Funk CJ; Wang J; Ito Y; Travanty EA; Voelker DR; Holmes KV; Mason RJ
J Gen Virol; 2012 Mar; 93(Pt 3):494-503. PubMed ID: 22090214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
